PatchSiren cyber security CVE debrief
CVE-2026-24165 NVIDIA CVE debrief
CVE-2026-24165 is a high-severity vulnerability in NVIDIA BioNeMo that allows deserialization of untrusted data, potentially leading to code execution, denial of service, information disclosure, and data tampering. The vulnerability has a CVSS score of 7.8 and is considered HIGH severity. This vulnerability exists in the NVIDIA BioNeMo Framework, specifically in the deserialization process. An attacker could exploit this vulnerability by providing malicious data. Users of NVIDIA BioNeMo Framework should be aware of this vulnerability and take necessary precautions to mitigate the risk. The vulnerability can be patched by applying the patch provided by NVIDIA.
- Vendor
- NVIDIA
- Product
- BioNeMo Framework
- CVSS
- HIGH 7.8
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-03-31
- Original CVE updated
- 2026-07-24
- Advisory published
- 2026-03-31
- Advisory updated
- 2026-07-24
Who should care
Users of NVIDIA BioNeMo Framework, operators, and security teams should be aware of this vulnerability and take necessary precautions to mitigate the risk. Affected deployments should be identified, and owners should be assigned for follow-up. Compensating controls should be reviewed for exposed systems while remediation is scheduled and verified.
Technical summary
The vulnerability exists in the NVIDIA BioNeMo Framework, specifically in the deserialization process. An attacker could exploit this vulnerability by providing malicious data, potentially leading to code execution, denial of service, information disclosure, and data tampering. The vulnerability has a CVSS score of 7.8 and is considered HIGH severity. Users should review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance.
Defensive priority
High priority should be given to patching this vulnerability, as it has a high CVSS score and could lead to significant impacts if exploited. Confirmed affected product deployments should be prioritized for patching.
Recommended defensive actions
- Apply the patch provided by NVIDIA
- Restrict access to the affected system
- Monitor for suspicious activity
- Implement compensating controls
- Verify system inventory and configuration
Evidence notes
The CVE record was published on 2026-03-31T17:16:31.727Z and last modified on 2026-07-24T20:10:00.147Z. The NVD entry is currently Analyzed. This vulnerability affects NVIDIA BioNeMo, which is a platform for building and deploying AI models. Users should verify their system inventory and configuration to determine if they are affected. The CVE record and NVD entry provide additional context and details about the vulnerability.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-24165 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-24165
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-24165 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-24165
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Mitigation or vendor reference
Unverified legacy reference
URL: https://nvidia.custhelp.com/app/answers/detail/a_id/5808
[email protected] - Vendor Advisory
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.